Serina sells AgeX assets to shareholder Juvenescence to become debt-free
Fecha de publicación:
15/01/2025
Fuente:FierceBiotech
Serina Therapeutics is shedding a subsidiary to start the new year off debt-free. The Alabama-based biotech has sold UniverXome Bioengineering to clear away $11.2 million in debt.